Meeting
2017 ASCO Quality Care Symposium
Oncopre: A new chemotherapy benefit prediction model to assist treatment decision making.
Authors
Dimas Yusuf
Cross Cancer Institute, Edmonton, AB, Canada
Dimas Yusuf, Maria Yi Ho, Winson Y. Cheung
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy in Quality; Practice of Quality
Track
Cost, Value, and Policy in Quality,Practice of Quality
Sub Track
Use of IT/Analytics to Improve Quality
Citation
J Clin Oncol 35, 2017 (suppl 8S; abstract 126)
DOI
10.1200/JCO.2017.35.8_suppl.126
Abstract #
126
Poster Bd #
E17
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
First-line anti-EGFR or anti-VEGF therapy, tumour sidedness, and survival: Results from the South Australian (SA) Metastatic Colorectal Cancer (mCRC) Registry.
First Author: Tharani Krishnan
Poster
2022 ASCO Annual Meeting
Label-free and automated approach to rapidly classify microsatellite instability (MSI) in early colon cancer (CC) analyzing the AIO ColoPredictPlus 2.0 (CPP) registry trial.
First Author: Stephanie Schörner
Poster
2022 ASCO Annual Meeting
The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC).
First Author: Jenny F. Seligmann
Poster
2019 ASCO Annual Meeting
Survival according to mutations in BRAF, KRAS, or microsatellite instability (MSI-H) after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastases from colorectal cancer.
First Author: Stein G Larsen